|
Volumn 15, Issue 7 II, 2002, Pages
|
Recent landmark clinical trials: How do they modify the therapeutic paradigm?
|
Author keywords
Calcium antagonists; Diabetes mellitus; Hypertension
|
Indexed keywords
AMLODIPINE;
ANGIOTENSIN 1 RECEPTOR ANTAGONIST;
ANGIOTENSIN 2 RECEPTOR ANTAGONIST;
ANTIHYPERTENSIVE AGENT;
CALCIUM ANTAGONIST;
IRBESARTAN;
LOSARTAN;
BLOOD PRESSURE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DIABETIC NEPHROPATHY;
HUMAN;
HYPERTENSION;
MICROALBUMINURIA;
MONOTHERAPY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PRIORITY JOURNAL;
UNITED STATES;
RENOVASCULAR HYPERTENSION;
REVIEW;
ANTIHYPERTENSIVE AGENTS;
CLINICAL TRIALS;
DIABETIC NEPHROPATHIES;
HUMANS;
HYPERTENSION, RENAL;
|
EID: 0036633151
PISSN: 08957061
EISSN: None
Source Type: Journal
DOI: 10.1016/s0895-7061(02)02948-5 Document Type: Conference Paper |
Times cited : (7)
|
References (13)
|